Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator

被引:0
|
作者
Kunzelmann, K [1 ]
Nitschke, R
机构
[1] Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia
[2] Univ Freiburg, Inst Physiol, D-7800 Freiburg, Germany
来源
EXPERIMENTAL NEPHROLOGY | 2000年 / 8卷 / 06期
关键词
cystic fibrosis transmembrane conductance regulator; CFTR; processing; traffic; cystic fibrosis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In most epithelial tissues C1(-) transport relies on the cystic fibrosis transmembrane conductance regulator (CFTR) which has dual function as a C1(-) channel and as a regulator of other ion channels. More than 900 different mutations in the CFTR gene are the cause for defective transport of C1(-) and Na+ and impaired secretion or absorption of electrolytes in cystic fibrosis, However, the CFTR mutation Delta F508 is the most common reason for the frequently inherited disease among the Caucasian population. Maturation and processing of Delta F508-CFTR is defective which leads to expression of only very little but functional CFTR in the cell membrane. Understanding the processing and trafficking of CFTR may give a clue to the question as to how the expression and residual function of Delta F508-CFTR can be enhanced, and may lead to the development of new pharmacological tools for the treatment of cystic fibrosis. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:332 / 342
页数:11
相关论文
共 50 条
  • [1] Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator
    Skach, WR
    KIDNEY INTERNATIONAL, 2000, 57 (03) : 825 - 831
  • [2] Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
    Carlile, Graeme W.
    Robert, Renaud
    Goepp, Julie
    Matthes, Elizabeth
    Liao, Jie
    Kus, Bart
    Macknight, Sean D.
    Rotin, Daniela
    Hanrahan, John W.
    Thomas, David Y.
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (01) : 16 - 25
  • [3] Cystic Fibrosis Transmembrane Conductance Regulator Intracellular Processing, Trafficking, and Opportunities for Mutation-Specific Treatment
    Rogan, Mark P.
    Stoltz, David A.
    Hornick, Douglas B.
    CHEST, 2011, 139 (06) : 1480 - 1490
  • [4] Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
    Pedemonte, Nicoletta
    Tomati, Valeria
    Sondo, Elvira
    Caci, Emanuela
    Millo, Enrico
    Armirotti, Andrea
    Damonte, Gianluca
    Zegarra-Moran, Olga
    Galietta, Luis J. V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (17) : 15215 - 15226
  • [5] The cystic fibrosis transmembrane conductance regulator and ATP
    Devidas, S
    Guggino, WB
    CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (04) : 547 - 552
  • [6] Where Is the Cystic Fibrosis Transmembrane Conductance Regulator?
    Barbry, Pascal
    Marcet, Brice
    Caballero, Ignacio
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1214 - 1216
  • [7] Biosynthesis of cystic fibrosis transmembrane conductance regulator
    Pranke, Iwona M.
    Sermet-Gaudelus, Isabelle
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 : 26 - 38
  • [8] THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    RIORDAN, JR
    ANNUAL REVIEW OF PHYSIOLOGY, 1993, 55 : 609 - 630
  • [9] Glycosylation and the cystic fibrosis transmembrane conductance regulator
    Scanlin, TF
    Glick, MC
    RESPIRATORY RESEARCH, 2001, 2 (05) : 276 - 279
  • [10] Cystic Fibrosis Transmembrane Conductance Regulator and Pseudomonas
    Zemanick, Edith T.
    Accurso, Frank J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 763 - 765